Bibliography

Export 10 results:
Filters: Author is Bronskill, S. E.  [Clear All Filters]
M
Maclagan L.C, Bronskill S.E, Guan J., Campitelli M.A, Herrmann N., Lapane K.L, Hogan D.B, Amuah J.E, Seitz D.P, Gill S.S et al..  2018.  Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission. J Am Med Dir Assoc. 19(11):959-966.e4.
Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.
Maxwell C.J, Bronskill S.E, Diong C., Hogan D.B, Patten S.B, Jette N., Marrie R.A.  2015.  Depressive symptom trajectories in older adults with dementia and associated risk of functional decline. Alzheimer's and Dementia. 11(7 SUPPL. 1):P873-P874.
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
Maxwell C.J, Vu M., Hogan D.B, Patten S.B, Jantzi M., Kergoat M.J, Jette N., Bronskill S.E, Heckman G., Hirdes J.P.  2013.  Patterns and determinants of dementia pharmacotherapy in a population-based cohort of home care clients. Drugs and Aging. 30(7):569-585.